Atria Investments, Inc - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 709 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.

Quarter-by-quarter ownership
Atria Investments, Inc ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q2 2024$212,232
-87.6%
6,255
-88.2%
0.00%
-90.6%
Q1 2023$1,714,889
-13.7%
53,010
-23.5%
0.03%
-22.0%
Q4 2022$1,987,050
+18.6%
69,331
-0.2%
0.04%
+10.8%
Q3 2022$1,675,000
+29.2%
69,448
+46.7%
0.04%
+37.0%
Q2 2022$1,296,000
-25.0%
47,335
+5.0%
0.03%
-10.0%
Q1 2022$1,729,000
+44.1%
45,089
+20.4%
0.03%
+42.9%
Q4 2021$1,200,000
+17.1%
37,461
+7.7%
0.02%
+10.5%
Q3 2021$1,025,000
-46.4%
34,785
-40.8%
0.02%
-54.8%
Q1 2021$1,911,000
+30.7%
58,800
+44.9%
0.04%
+20.0%
Q4 2020$1,462,000
-56.8%
40,593
-53.0%
0.04%
-66.0%
Q3 2020$3,384,000
+24.4%
86,410
+16.5%
0.10%
+10.8%
Q2 2020$2,720,000
+914.9%
74,158
+639.2%
0.09%
+830.0%
Q3 2019$268,000
+6.8%
10,032
+15.3%
0.01%
+11.1%
Q2 2019$251,000
-32.2%
8,703
-46.1%
0.01%
-55.0%
Q3 2017$370,000
-13.6%
16,134
-16.7%
0.02%
-23.1%
Q2 2017$428,000
+29.7%
19,364
+33.9%
0.03%
+23.8%
Q1 2017$330,000
-29.3%
14,457
-35.2%
0.02%
-41.7%
Q4 2016$467,00022,3230.04%
Other shareholders
VANECK VECTORS ETF TR shareholders Q2 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders